Compare Nomura Holdings Inc (NMR) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs Select Medical Holdings Corporation — how do they compare? Nomura Holdings Inc trades at $9.81 (market cap $27.46B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Nomura Holdings Inc is far larger — about 13.4× Select Medical Holdings Corporation's market cap, and Nomura Holdings Inc pays the higher dividend (3.45%). Which is the better fit depends on your goals.
| NMR | SEM | |
|---|---|---|
Market Cap | $27.46B | $2.05B |
Sector | Financials | Health |
52-Week High | $10.04 | $16.66 |
52-Week Low | $6.39 | $11.77 |
Dividend Yield | 3.45% | 1.51% |
Enterprise Value | — | $5.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nomura Holdings (NMR) trades at $9.81, up 4.36% with a bullish technical signal from moving averages. The company reported record annual profit of $340.74 billion for 2025, with revenue growing to $1.66 trillion and profit margin expanding to 20.49%. Recent news highlights strong wholesale revenue growth exceeding 30% and strategic acquisitions in US asset management. The stock trades at a P/E of 12.77, below industry averages, suggesting potential undervaluation.
Outlook remains positive with continued wholesale business momentum and global expansion initiatives. Key risks include integration costs from recent acquisitions and potential market volatility. Analyst consensus shows 33% buy ratings with no sell recommendations, indicating cautious optimism. The combination of reasonable valuation and strong fundamental performance supports potential upside.
Select Medical (SEM) trades at $16.51, unchanged on the day, amid a completed acquisition by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock shows a bullish technical signal with support and resistance clustered around $17. Financially, the company reported 2025 revenue of $5.45B and net income of $146.22M, with a P/E of 15.43 and P/S of 0.36 indicating moderate valuation. Recent earnings have been mixed, with a beat in Q3 2025 but misses in Q4 2025 and Q1 2026.
The acquisition at $16.50 per share caps near-term upside, with legal investigations into the board's fiduciary duties posing a key risk. Analyst sentiment is mixed with 35.71% buy ratings but 57.15% hold, reflecting uncertainty post-buyout. Investors should note the stock's limited movement potential given the acquisition price, with fundamental performance and legal outcomes driving any residual value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
